[DPHARMA] QoQ Cumulative Quarter Result on 31-Mar-2018 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
28-May-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Mar-2018 [#1]
Profit Trend
QoQ- -74.63%
YoY- 25.11%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 498,722 383,088 257,250 133,259 467,987 355,734 240,355 62.46%
PBT 59,666 42,008 26,170 13,255 51,796 38,971 24,764 79.43%
Tax -12,025 -8,736 -5,184 -2,608 -9,696 -8,639 -5,559 67.02%
NP 47,641 33,272 20,986 10,647 42,100 30,332 19,205 82.94%
-
NP to SH 47,641 33,272 20,986 10,782 42,492 30,622 19,217 82.87%
-
Tax Rate 20.15% 20.80% 19.81% 19.68% 18.72% 22.17% 22.45% -
Total Cost 451,081 349,816 236,264 122,612 425,887 325,402 221,150 60.62%
-
Net Worth 483,173 501,487 209,983 206,429 479,809 474,230 463,071 2.86%
Dividend
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Div 36,403 9,897 4,199 - 23,711 - 6,973 200.03%
Div Payout % 76.41% 29.75% 20.01% - 55.80% - 36.29% -
Equity
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Net Worth 483,173 501,487 209,983 206,429 479,809 474,230 463,071 2.86%
NOSH 661,881 661,881 650,902 278,959 278,959 278,959 278,959 77.61%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 9.55% 8.69% 8.16% 7.99% 9.00% 8.53% 7.99% -
ROE 9.86% 6.63% 9.99% 5.22% 8.86% 6.46% 4.15% -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
RPS 75.35 58.06 91.88 47.77 167.76 127.52 86.16 -8.52%
EPS 7.26 5.09 3.22 3.82 15.09 10.87 6.88 3.63%
DPS 5.50 1.50 1.50 0.00 8.50 0.00 2.50 68.91%
NAPS 0.73 0.76 0.75 0.74 1.72 1.70 1.66 -42.08%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
RPS 51.81 39.79 26.72 13.84 48.61 36.95 24.97 62.46%
EPS 4.95 3.46 2.18 1.12 4.41 3.18 2.00 82.66%
DPS 3.78 1.03 0.44 0.00 2.46 0.00 0.72 201.15%
NAPS 0.5019 0.5209 0.2181 0.2144 0.4984 0.4926 0.481 2.86%
Price Multiplier on Financial Quarter End Date
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Date 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 -
Price 0.95 1.23 1.30 2.80 2.53 2.20 2.25 -
P/RPS 1.26 2.12 1.41 5.86 1.51 1.73 2.61 -38.37%
P/EPS 13.20 24.39 17.34 72.44 16.61 20.04 32.66 -45.24%
EY 7.58 4.10 5.77 1.38 6.02 4.99 3.06 82.77%
DY 5.79 1.22 1.15 0.00 3.36 0.00 1.11 199.86%
P/NAPS 1.30 1.62 1.73 3.78 1.47 1.29 1.36 -2.95%
Price Multiplier on Announcement Date
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Date 18/02/19 28/11/18 26/11/18 28/05/18 28/02/18 17/11/17 25/08/17 -
Price 1.03 1.07 1.08 3.35 2.97 2.20 2.03 -
P/RPS 1.37 1.84 1.18 7.01 1.77 1.73 2.36 -30.34%
P/EPS 14.31 21.22 14.41 86.67 19.50 20.04 29.47 -38.13%
EY 6.99 4.71 6.94 1.15 5.13 4.99 3.39 61.78%
DY 5.34 1.40 1.39 0.00 2.86 0.00 1.23 165.41%
P/NAPS 1.41 1.41 1.44 4.53 1.73 1.29 1.22 10.10%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment